Tuesday, August 19, 2025
StockstToday.com Logo
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings
No Result
View All Result
StocksToday.com Logo
No Result
View All Result
Home Breaking News

Analyst Ratings and Price Targets for Equifax

Elaine Mendonca by Elaine Mendonca
February 9, 2024
in Breaking News
0
Finance_Commercial (2)
0
SHARES
0
VIEWS
Share on FacebookShare on Twitter

As of February 9, 2024, a total of 13 financial analysts have shared their ratings on Equifax (NYSE:EFX) in the last three months. Let’s take a look at their recent assessments and compare them to the previous months:

– Bullish: Out of the 13 analysts, 7 have provided a bullish rating for Equifax. In the last 30 days, 1 analyst rated it as bullish, while there were no bullish ratings one month ago. However, 4 analysts were bullish two months ago, and 2 analysts were bullish three months ago.

– Somewhat Bullish: 2 analysts have given a somewhat bullish rating for Equifax. There were no recent ratings in the last 30 days, but 2 analysts had a somewhat bullish view two months ago. There were no such ratings three months ago.

– Indifferent: 4 analysts have expressed an indifferent stance towards Equifax. None of them have provided a recent rating in the last 30 days. However, 1 analyst was indifferent one month ago, and both 1 analyst and 2 analysts were indifferent two months ago and three months ago, respectively.

– Somewhat Bearish and Bearish: There have been no analysts who rated Equifax as somewhat bearish or bearish in the past three months.

Looking at the average 12-month price target for Equifax, it stands at $267.0. The highest estimate is $315.00, while the lowest estimate is $195.00. This reflects a significant 36.45% increase from the previous average price target of $195.67. In the current month, Equifax has received 15 Buy Ratings, 7 Hold Ratings, and 0 Sell Ratings, with an average analyst price target of $275.07.

Recent analyst actions have included a range of ratings and adjustments to price targets. For instance, Kyle Peterson from Needham has maintained a Buy rating for Equifax with a price target of $305.00. On the other hand, Simon Clinch from Redburn Atlantic has announced a Neutral rating with a price target of $272.00.

To summarize, the majority of analysts have provided positive ratings for Equifax, suggesting an upside potential for the stock. However, it is crucial to consider a diverse range of perspectives and conduct thorough research before making any investment decisions.

Equifax Inc. (EFX) Demonstrates Strong Performance in Stock Market, Attracting Investor Attention

On February 9, 2024, Equifax Inc. (EFX) showcased a strong performance in the stock market. Trading near the top of its 52-week range and above its 200-day simple moving average, EFX exhibited positive price momentum and caught the attention of investors.

The price of EFX shares witnessed a significant increase of $10.20 since the market last closed, representing a rise of 4.22%. Closing at $252.06, the stock demonstrated its strength and potential for further growth.

Even after the market closed, EFX continued its upward trajectory in after-hours trading. The stock rose an additional $1.93, indicating sustained investor interest and confidence in the company’s future prospects.

EFX’s strong performance can be attributed to several factors. Firstly, trading near the top of its 52-week range indicates that the stock has been consistently performing well over the past year. This suggests that investors have been bullish on EFX and have continued to support its growth.

Moreover, EFX’s ability to stay above its 200-day simple moving average is another positive sign. The 200-day moving average is a widely followed technical indicator that helps identify the overall trend of a stock. When a stock remains above its 200-day moving average, it suggests that the stock is in an uptrend and has the potential to continue rising.

The rise in EFX’s stock price on February 9, 2024, can be seen as a reflection of the company’s strong fundamentals and positive market sentiment. Equifax Inc. is a leading global data, analytics, and technology company that provides information solutions to businesses and consumers. With its extensive data resources and advanced analytics capabilities, EFX has positioned itself as a key player in the industry.

Investors are likely optimistic about EFX’s future prospects, considering the company’s ability to generate revenue and deliver value to its customers. As businesses increasingly rely on data-driven insights to make informed decisions, Equifax’s services become even more valuable.

While past performance is not indicative of future results, EFX’s strong showing on February 9, 2024, suggests that the stock may continue to attract investor attention and potentially deliver further gains. However, it is important for investors to conduct thorough research and consider various factors before making investment decisions.

Equifax Inc. Financial Performance: Steady Revenue but Decline in Net Income and EPS

On February 9, 2024, Equifax Inc. (EFX) showcased its financial performance for the past year and the fourth quarter. Total revenue has remained steady for Equifax over the past year, amounting to $5.26 billion. However, the net income for EFX tells a different story. Over the course of the past year, Equifax recorded a net income of $545.30 million, a decrease of 21.67% compared to the previous year. The earnings per share (EPS) for Equifax also experienced a decline, with an EPS of $4.40 over the past year, a decrease of 22.07% compared to the previous year. These figures indicate that while Equifax managed to maintain a stable total revenue, its net income and earnings per share experienced a decline. Investors and stakeholders in Equifax might be concerned about the decline in net income and EPS. External factors such as changes in market conditions, increased competition, or regulatory challenges could have impacted Equifax’s ability to generate higher profits. It is also important to assess the company’s internal strategies and initiatives to address these challenges and improve its financial standing. Investors should consider these figures in conjunction with other relevant information to gain a holistic view of Equifax’s financial standing and make informed investment choices.

Tags: EFX
Elaine Mendonca

Elaine Mendonca

Related Posts

NFT projects
Breaking News

The Impact of TikToks Fate on USChina Relations and American Tech Giants

March 16, 2024
Businesses finance
Breaking News

Blackstone Strategic Credit 2027 Term Fund BGB Announces Monthly Dividend of 93 Cents per Share

March 15, 2024
Healthcare-sector
Breaking News

Analyzing Short Interest in Molina Healthcare Inc MOH

March 15, 2024
Next Post
Biotechnology Markets and money

Humacytes Revolutionary Human Acellular Vessel Receives Priority Review from FDA

AMETEK Inc Announces Impressive Increase in Quarterly Dividend

Technology Cloud computing Trading online

AgEagle Aerial Systems Implements Reverse Stock Split to Maintain NYSE American Listing

Recommended

MA stock news

Rail Visions Shares Experience Dramatic Surge in Stock Price

2 years ago
CTVA stock news

Unveiling the Mysterious Alter Ego of Microsofts Copilot Meet Sydney

1 year ago

First Wave BioPharma Revolutionizes Treatment for Celiac Disease with Groundbreaking Therapy

2 years ago
MYRG stock news

Stonnington Group LLC Acquires 6,700 Shares of Sea Limited: Potential Impacts on the Global Market

2 years ago

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

Topics

AAL AAPL ABNB ADBE ADSK ALB AMD AMZN AVGO BA C CCL CELH COIN COST CRWD CTVA DELL DFS DIS DLR DLTR DWAC GM GRFS IBM INTC JPM KSS LLY META MSFT NFLX NVDA NVO ORCL PARA PLTR PLUG QCOM SMCI TGT TSLA UNH VZ
No Result
View All Result

Highlights

Leadership Shift and Lucrative Government Deal Signal Potential Turnaround for CoreCivic

Savara Biotech Nears Pivotal Moment with Promising Lung Disease Treatment

Agios Pharmaceuticals Navigates Financial Turbulence Amid Promising Clinical Developments

Broadcom Executives Cash Out Amid Diverging Market Sentiment

Kodak’s Survival Hangs in the Balance as Debt Crisis Deepens

Iovance Secures Landmark Canadian Approval for Breakthrough Cancer Therapy

Trending

Brookline Stock
Stocks

Brookline Shares Extend Decline Amid Mixed Technical Signals

by Robert Sasse
August 19, 2025
0

Brookline's stock continued its downward trajectory, slipping another 0.3% in Thursday's session to mark its third consecutive...

PayPal Stock

PayPal Faces Security Scrutiny Amid Conflicting Data Breach Claims

August 19, 2025
Evolus Stock

Evolus Shares Plunge as Earnings Miss Sparks Growth Concerns

August 19, 2025
CoreCivic Stock

Leadership Shift and Lucrative Government Deal Signal Potential Turnaround for CoreCivic

August 19, 2025
Savara Stock

Savara Biotech Nears Pivotal Moment with Promising Lung Disease Treatment

August 19, 2025

StocksToday.com is your one-stop destination for the latest stock news and analysis. We provide in-depth coverage of the stock market, including market news, company news, sector news, IPO news, investment strategies, personal finance, international markets, and more.

Recent News

  • Brookline Shares Extend Decline Amid Mixed Technical Signals August 19, 2025
  • PayPal Faces Security Scrutiny Amid Conflicting Data Breach Claims August 19, 2025
  • Evolus Shares Plunge as Earnings Miss Sparks Growth Concerns August 19, 2025

Categories

  • Analyst Ratings
  • Breaking News
  • Business & Industry Trends
  • ETF
  • Market News
  • Stock Picks
  • Stock Targets
  • Stocks
  • Uncategorized

© 2024 Stocks Today

No Result
View All Result
  • Home
  • Breaking News
  • Business & Industry Trends
  • Market News
  • Analyst Ratings

© 2023 StocksToday.com